Arkolith/Insider Trading/TCON/Form 4

Opaleye Management Inc.

10% OwnerTracon Pharmaceuticals, Inc. (TCON) · full profile →Form 4 · filed May 10, 2022
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 10, 2022Buy(P)1K$1.76$2K337K
May 10, 2022Buy(P)9K$1.76$15K2.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-012746) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML